These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 443942)
21. Clinical and pathophysiologic changes in patients on chronic dialysis: the central nervous system. Kerr DN Adv Nephrol Necker Hosp; 1980; 9():109-32. PubMed ID: 6773310 [No Abstract] [Full Text] [Related]
22. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum. Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004 [No Abstract] [Full Text] [Related]
23. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators. Fraser CL; Arieff AI New Horiz; 1994 Nov; 2(4):518-26. PubMed ID: 7804801 [TBL] [Abstract][Full Text] [Related]
25. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. Lillevang ST; Pedersen FB Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071 [No Abstract] [Full Text] [Related]
26. The use of desferrioximine in dialysis-associated aluminium disease. Ackrill P; Day JP Contrib Nephrol; 1993; 102():125-34. PubMed ID: 8416177 [No Abstract] [Full Text] [Related]
36. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure. Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766 [No Abstract] [Full Text] [Related]
37. Role of plasma aluminum in the detection and prevention of aluminum toxicity. Winney RJ; Cowie JF; Robson JS Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005 [No Abstract] [Full Text] [Related]
38. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)]. Galle P; Chatel M; Berry JP; Menault F Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824 [TBL] [Abstract][Full Text] [Related]
39. Aluminum and phosphate. Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042 [No Abstract] [Full Text] [Related]
40. [Encephalopathy in patients with terminal renal insufficiency undergoing treatment with regular hemodialysis]. Nikiforov AS; Soldatova SA; Potomskaia LE; Vinarskaia EN; Ermolenko VM Ter Arkh; 1977; 49(7):67-70. PubMed ID: 898080 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]